FDA, COVID and Vaccine
Digest more
The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for chikungunya, a virus transmitted by mosquitoes.
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.
2hon MSN
As the deadly measles outbreak in West Texas has continued to grow, parents have reportedly been racing to get their kids vaccinated. New data from the Electronic Health Record data analysis company Truveta has documented the surge,
The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya, a mosquito-borne virus. The recommendations were approved on May 13, 2025,
The Trump administration plans to drop routine COVID vaccination guidance for kids and pregnant women, marking a major shift in federal health policy, according to a report.
5d
MedPage Today on MSNCDC to Pull COVID Vax Recommendations; NIH Cut Autism Funding; Florida Bans FluorideKennedy Jr. plans to remove CDC recommendations for COVID-19 vaccination in pregnant women and children. Come the fall, it may just be older adults and people with comorbidities who are urged to get a COVID shot.
FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.”